EGFR and cancer: More recently, the Lin group used a functional genomics approach to identify a transmembrane protein of unknown function, TMEM43 (also referred as LUMA) as a new CARMA3-binding partner that serves as a critical mediator of EGFR-induced NF-κB activation in cancer cells (119).